Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community (MOSAR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2008 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00773799
First received: October 6, 2008
Last updated: October 15, 2008
Last verified: October 2008
  Purpose

Data on occurrence of antimicrobial resistant bacteria acquisition in rehabilitation centers will be collected. After removal of patient identifiers, information regarding the patients population will be entered into electronic sheet. The phase will last twelve months in each center.


Condition
ESBL Infection
Methicillin-Resistant Staphylococcus Aureus

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community

Resource links provided by NLM:


Further study details as provided by Tel-Aviv Sourasky Medical Center:

Primary Outcome Measures:
  • A rehabilitation center's department in which the hospitalized patients are older then 18 years old. [ Time Frame: 1 YEAR ] [ Designated as safety issue: No ]

Estimated Enrollment: 1200
Study Start Date: October 2008
Estimated Study Completion Date: January 2014
Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
rehabilitation center's hospitalized patients

Detailed Description:

All patients admitted to the department will be examined on admission, two weeks latter and monthly by obtaining nares and perirectal cultures. These cultures will be processed for detection the target organisms. This activity is part of the good medical practice and is performed on routine basis in various hospital units

Epidemiological data will be collected from patient records. This data will be stored after removal of all patients' identifiers. These data will be transferred for analysis to Tel Aviv Medical Center

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

A rehabilitation center's department in which the hospitalized patients are older then 18 years old.

Criteria

Inclusion Criteria:

  • Hospitalized patients are older then 18 years old

Exclusion Criteria:

  • Age 18 years or less
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00773799

Contacts
Contact: yaffa lerman, MD 97252-4266910 yaffale@tasmc.health.gov.il

Locations
Israel
Tasmc Not yet recruiting
Tel-aviv, Israel, 64239
Contact: Yaffa lerman, md    97252-4266910    yaffale@tasmc.health.gov.il   
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Yehuda carmeli, MD MPH TASMC
  More Information

Publications:

Responsible Party: yehuda carmeli, TASMC
ClinicalTrials.gov Identifier: NCT00773799     History of Changes
Other Study ID Numbers: TASMC-08-YC-239-CTIL
Study First Received: October 6, 2008
Last Updated: October 15, 2008
Health Authority: Israel: Ministry of Health

Keywords provided by Tel-Aviv Sourasky Medical Center:
To define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and
To define specific risk factors for acquisition of resistant bacteria (ESBL producers and MRSA) in rehabilitation centers.
ESBL producers
MRSA

Additional relevant MeSH terms:
Staphylococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 17, 2014